Phenytoin in the treatment of cocaine abuse: a double-blind study. (Q51575232)

7 April 2018

title

Phenytoin in the treatment of cocaine abuse: a double-blind study. (English)

1 reference

7 April 2018

1 reference

1 reference

Crosby RD

1

1 reference

7 April 2018

Pearson VL

2

1 reference

7 April 2018

Eller C

3

1 reference

7 April 2018

Winegarden T

4

1 reference

7 April 2018

Graves NL

5

1 reference

7 April 2018

language of work or name

English

0 references

publication date

1 April 1996

1 reference

7 April 2018

Clinical Pharmacology & Therapeutics

published in

1 reference

7 April 2018

volume

59

1 reference

7 April 2018

issue

4

1 reference

7 April 2018

page(s)

458-468

1 reference

7 April 2018

New pharmacotherapies for cocaine dependence ... revisited

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990116-2

Some conceptual and statistical issues in analysis of longitudinal psychiatric data. Application to the NIMH treatment of Depression Collaborative Research Program dataset

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990116-2

Naltrexone in the treatment of alcohol dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990116-2

Desipramine treatment of cocaine dependence in methadone-maintained patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990116-2

Pharmacotherapy for cocaine-abusing methadone-maintained patients using amantadine or desipramine

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990116-2

The Effect of Carbamazepine on Cocaine Use

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990116-2

Crack cocaine use: a review of prevalence and adverse effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990116-2

Pathophysiological effects of cocaine in humans: review of scientific issues

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990116-2

Inpatient and day hospital treatment services for cocaine and alcohol dependence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990116-2

Effectiveness and costs of inpatient versus day hospital cocaine rehabilitation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990116-2

Pharmacotherapeutic interventions for cocaine abuse: present practices and future directions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990116-2

Current pharmacotherapies for cocaine abuse: a review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990116-2

Carbamazepine for cocaine addiction?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990116-2

Treatment of crack cocaine use with carbamazepine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990116-2

Reduction of Cocaine Use Among Methadone Maintenance Patients Using Concurrent Carbamazepine Maintenance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990116-2

Cocaine reduction in unmotivated crack users using carbamazepine versus placebo in a short-term, double-blind crossover design

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990116-2

Impact of desipramine or carbamazepine on patient retention in outpatient cocaine treatment: preliminary findings.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990116-2

Carbamazepine treatment of cocaine dependence: a placebo-controlled trial.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990116-2

Double-blind comparison of carbamazepine and placebo for treatment of cocaine dependence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990116-2

Carbamazepine treatment for cocaine dependence.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990116-2

Intraperitoneal phenytoin suppresses kindled responses: effects on motor and electrographic seizures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990116-2

Phenytoin potently increases the threshold for focal seizures in amygdala-kindled rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990116-2

Quantitative Cocaine Urine Testing in Clinical Research Settings

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990116-2

Measuring outcome in the treatment of cocaine abuse: the Drug Impairment Rating Scale for cocaine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990116-2

The measurement of craving in cocaine patients using the Minnesota Cocaine Craving Scale.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990116-2

Random-effects models for serial observations with binary response.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990116-2

Mechanisms of anticonvulsant drug action. I. Drugs primarily used for generalized tonic-clonic and partial epilepsies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990116-2

Comparison of Amantadine and Desipramine Combined with Psychotherapy for Treatment of Cocaine Dependence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990116-2

10.1016/S0009-9236(96)90116-2

7 January 2021

Identifiers

DOI

1 reference

7 April 2018

PubMed ID

8612392

1 reference

7 April 2018